Business · 27/04/1998Updated: 10/17/2026 · 1 min read
FDA Proposes Changes to PMA Supplement Review Process
Summary
The FDA is proposing to allow companies to submit a 30-day notice for modifications to manufacturing procedures or methods of manufacture, as part of revisions to the Federal Food, Drug, and Cosmetic Act implemented by the Food and Drug Administration Modernization Act of 1997.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →